Investors looking for consumer discretionary exposure often turn to one of two distinct exchange-traded funds: the globally diversified iShares Global Consumer Discretionary ETF (RXI) and the U.S.-centric Consumer Discretionary Select Sector SPDR Fund (XLY). Both track the same broad theme but differ in structure, costs, and risk characteristics. In my view, comparing how each is constructed helps clarify which one aligns better with specific portfolio goals.
RXI tracks the S&P Global 1200 Consumer Discretionary Sector Capped Index. Launched in September 2006, it holds roughly 140 stocks across developed and emerging markets, offering one-ticket access to global producers of non-essential goods and services. Because the index is capitalization-weighted and capped, no single name dominates. Top holdings include AMZN (roughly 15–16%), TSLA (about 6–7%), HD, Alibaba, Toyota Motor, MCD, TJX, LVMH, BKNG, and LOW. U.S. issuers make up about 60% of assets, with the rest spread across Japan, China, France, Germany, and the U.K. The fund’s 0.37% expense ratio suits investors who value diversification and international reach.
XLY tracks the Consumer Discretionary Select Sector Index within the S&P 500. Launched in December 1998, it ranks among the larger and more liquid products in its category. The fund holds roughly 50 large-cap U.S. stocks and is market-capitalization weighted, which leads to notable concentration. Top holdings include AMZN (about 23–24%), TSLA (roughly 17–19%), HD, MCD, BKNG, TJX, SBUX, LOW, DASH, and GM. Its 0.08% expense ratio and U.S.-only mega-cap focus result in higher beta and greater sensitivity to individual names.
Both funds operate in the consumer discretionary sector, so their performance ties closely to household spending, employment, interest rates, and consumer confidence. Discretionary stocks react sharply to borrowing costs, with higher rates pressuring autos and home improvement while services like travel and dining have held up better. E-commerce and digital platforms keep AMZN and TSLA as major influences in both portfolios. Regulatory and trade issues add complexity, particularly for RXI’s international holdings. From what I see, the main difference lies less in the names held and more in concentration and geographic scope.
Recent periods show the funds moving in similar directions but with different magnitudes. XLY’s heavier weights in Tesla and Amazon amplify both gains and losses, while its domestic focus links it tightly to U.S. earnings and rate expectations. RXI’s broader diversification tends to moderate single-stock impacts, though currency and regional factors introduce additional variables. I also checked this using Tickeron’s AI Screener to see how the two compare on volatility and trend metrics. Overall, XLY has shown higher volatility, whereas RXI has delivered more tempered results. The choice often hinges on whether concentrated U.S. momentum or diversified global balance better matches an investor’s risk tolerance.
I frequently turn to Tickeron’s AI Screener when comparing ETFs like these. The tool lets me apply technical patterns, fundamentals, and AI signals across thousands of securities to quickly surface ideas that align with a given strategy. It has helped refine my own views on sector exposure without replacing broader fundamental analysis.
After weighing cost efficiency, liquidity, diversification, and risk exposure, Tickeron’s AI currently favors XLY. The 0.08% expense ratio, strong liquidity, and focus on leading U.S. consumer names provide a measurable advantage in cost-adjusted performance and signal consistency. RXI remains a solid option for those seeking broader global diversification and lower single-name concentration. This preference is probabilistic and could shift with evolving market conditions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for RXI turned positive on October 05, 2026. Looking at past instances where RXI's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RXI's RSI Indicator exited the oversold zone, 24 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on RXI as a result. In 64 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
RXI moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for RXI crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Following a +0.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where RXI advanced for three days, in 227 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 173 of 230 cases where RXI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 55 of 63 cases where RXI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
RXI broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category Unknown